General MedicationsORALGeneric

FOSAMAX

ALENDRONATE SODIUM

Standard Dose

EQ 70MG BASE/75ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview FOSAMAX is listed in Drugs@FDA under application 021575 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ALENDRONATE SODIUM Form and strength SOLUTION;ORAL - EQ 70MG BASE/75ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MERCK Submission history Latest submission status date: 2015-11-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview FOSAMAX is listed in Drugs@FDA under application 021575 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ALENDRONATE SODIUM Form and strength SOLUTION;ORAL - EQ 70MG BASE/75ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MERCK Submission history Latest submission status date: 2015-11-30 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.